MEI Pharma Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for MEI Pharma stock has a target of 7.00, which predicts an increase of 180.00% from the current stock price of 2.50.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$7.00	$7.00	$7.00	$7.00
Change	+180.00%	+180.00%	+180.00%	+180.00%

* Price targets were last updated on Apr 12, 2024.

Analyst Ratings

The average analyst rating for MEI Pharma stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yale Jen Laidlaw & Co.	Laidlaw & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jul 23, 2024
Stephen Willey Stifel	Stifel	Hold Maintains $7	Hold	Maintains	$7	+180.00%	Apr 12, 2024
Stephen Willey Stifel	Stifel	Hold Maintains $8 → $7	Hold	Maintains	$8 → $7	+180.00%	Feb 14, 2024
Stephen Willey Stifel	Stifel	Hold Maintains $10 → $9	Hold	Maintains	$10 → $9	+260.00%	Sep 27, 2023
Leah Cann Brookline Capital	Brookline Capital	Strong Buy Maintains $80	Strong Buy	Maintains	$80	+3,100.00%	May 23, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

6.38M

from 65.30M

-90.24%

from 65.30M

Revenue Next Year

25.50M

from 6.38M

300.00%

from 6.38M

EPS This Year

-5.80

from 2.67

EPS Next Year

-3.78

from -5.80

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2020	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	27.76M	34.80M	40.70M	48.82M	65.30M	6.38M	25.50M
Revenue Growth	464.72%	25.36%	16.96%	19.95%	33.76%	-90.24%	300.00%
EPS	-10.36	-12.00	-9.99	-4.78	2.67	-5.80	-3.78
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	13.1M	26.3M
Avg	6.4M	25.5M
Low	n/a	24.5M

Revenue Growth

Revenue Growth	2025	2026
High	-79.9%	311.8%
Avg	-90.2%	300.0%
Low	-	284.3%

EPS Forecast

EPS	2025	2026
High	-5.35	-3.90
Avg	-5.80	-3.78
Low	-6.15	-3.64

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.